Boyce - Bynum Pathology Laboratories, INC

Boyce - Bynum Pathology Laboratories, INC was paid $1.87M by Medicaid between Jan 2018 and Feb 2019, across 164 billing codes. Its largest line is G0482, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed — 9.9% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Missouri

Rank by total paid#11 of 61

Median peer was paid$85K

This provider vs. median22×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	141,855	$1.71M
2019	9,862	$160K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	9.9%	3,686	2,854	$185K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	9.8%	3,322	2,400	$183K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	4.4%	219	215	$81K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	3.8%	2,576	2,410	$71K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	3.8%	2,582	2,408	$71K
80050	General health panel	2.9%	1,387	1,341	$54K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	2.9%	822	786	$54K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	2.9%	2,482	2,335	$53K
80061	Lipid panel	2.8%	5,057	4,837	$52K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.7%	10,635	8,641	$51K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	2.7%	1,578	1,502	$51K
80053	Comprehensive metabolic panel	2.6%	8,331	7,470	$49K

152 more codes

84443	Thyroid stimulating hormone (TSH)	2.4%	4,095	$44K
83036	Hemoglobin; glycosylated (A1C)	1.9%	4,874	$35K
80356		1.6%	2,076	$31K
80361		1.5%	2,082	$28K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	1.4%	1,065	$26K
80348		1.4%	2,107	$25K
80354		1.3%	2,099	$25K
80346		1.3%	2,019	$24K
87086	Culture, bacterial; quantitative colony count, urine	1.2%	3,709	$22K
86780		1.2%	1,682	$22K
80358		1.1%	1,953	$21K
80325		1.1%	2,019	$20K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.1%	1,306	$20K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.0%	1,998	$20K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.0%	590	$19K
80365		<1%	2,057	$19K
80372		<1%	2,067	$18K
80353		<1%	1,982	$18K
84439		<1%	2,199	$17K
80357		<1%	1,984	$17K
80360		<1%	2,010	$17K
80359		<1%	1,992	$17K
80369		<1%	1,940	$16K
80373		<1%	2,048	$16K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	402	$14K
80362		<1%	1,138	$14K
87070		<1%	1,753	$14K
83655		<1%	1,070	$13K
80349		<1%	1,185	$11K
87581		<1%	241	$10K
87486		<1%	242	$10K
86803		<1%	1,078	$10K
87186		<1%	1,518	$10K
87077		<1%	1,565	$9K
84146		<1%	496	$9K
88141		<1%	381	$9K
80164		<1%	874	$9K
82607		<1%	949	$9K
80048	Basic metabolic panel (calcium, ionized)	<1%	2,399	$8K
87081		<1%	1,254	$8K
80074		<1%	184	$8K
83992		<1%	1,933	$8K
80363		<1%	885	$7K
84481		<1%	478	$7K
87340		<1%	724	$7K
83880		<1%	372	$6K
87400		<1%	284	$6K
86696		<1%	279	$5K
86762		<1%	379	$5K
88142		<1%	277	$5K
82140		<1%	366	$4K
82728		<1%	412	$4K
36415	Collection of venous blood by venipuncture	<1%	2,431	$4K
86235		<1%	106	$4K
80351		<1%	194	$4K
85027		<1%	778	$4K
84134		<1%	309	$4K
85610		<1%	1,959	$3K
86003		<1%	56	$3K
84403		<1%	168	$3K
86850		<1%	449	$3K
80177		<1%	307	$3K
84702		<1%	243	$3K
87522	Neg quan hep c or qual rna	<1%	285	$3K
86695		<1%	220	$3K
84436		<1%	541	$3K
82746		<1%	290	$3K
80076		<1%	645	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	191	$3K
80178		<1%	384	$2K
87075		<1%	311	$2K
86757		<1%	64	$2K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	103	$2K
83540		<1%	458	$2K
81001		<1%	1,332	$2K
84703		<1%	281	$2K
83550		<1%	308	$2K
82128		<1%	206	$2K
82261		<1%	206	$2K
82760		<1%	206	$2K
82725		<1%	204	$2K
83919		<1%	202	$2K
84153		<1%	178	$2K
87147		<1%	390	$2K
82950		<1%	411	$2K
86706		<1%	194	$2K
85013		<1%	356	$2K
86038		<1%	162	$2K
87493		<1%	65	$2K
86704		<1%	166	$2K
83735		<1%	427	$2K
87481		<1%	63	$1K
83516		<1%	84	$1K
81003		<1%	959	$1K
86140		<1%	356	$1K
87511		<1%	62	$1K
84550		<1%	455	$1K
86665		<1%	48	$1K
86901		<1%	386	$1K
86900		<1%	388	$1K
80185		<1%	202	$1K
87046		<1%	156	$1K
86225		<1%	118	$1K
82947		<1%	299	$1K
84030		<1%	201	$1K
86618		<1%	60	$917.38
82977		<1%	1,116	$886.85
87045		<1%	97	$837.38
86480		<1%	36	$827.07
86709		<1%	121	$752.31
82785		<1%	45	$736.45
82570		<1%	195	$735.83
86664		<1%	45	$700.32
83001		<1%	40	$686.39
85652		<1%	339	$679.39
86666		<1%	56	$653.45
87427		<1%	62	$637.85
86663		<1%	46	$619.55
84144		<1%	27	$550.20
83020		<1%	180	$518.43
82670		<1%	28	$515.45
83970		<1%	28	$510.50
87530		<1%	12	$454.91
86708		<1%	50	$338.77
84479		<1%	64	$336.43
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	5,221	$331.63
83525		<1%	30	$320.70
83690		<1%	58	$315.14
82043		<1%	77	$267.41
86308		<1%	50	$249.98
82274		<1%	38	$219.68
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	5,455	$212.53
82550		<1%	41	$186.23
36416		<1%	62	$179.66
80156		<1%	15	$175.02
80162		<1%	27	$164.43
82951		<1%	15	$160.30
86376		<1%	12	$157.96
86431		<1%	40	$152.39
82150		<1%	32	$143.52
80069		<1%	54	$122.57
83615		<1%	15	$72.82
86689		<1%	15	$71.70
82952		<1%	15	$55.76
80374		<1%	14	$45.92
84132		<1%	37	$41.98
84156		<1%	13	$35.09
80366		<1%	13	$22.96
99082		<1%	190	$1.20
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	189	$1.14
87536		0%	14	$0.00
80324		0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOTTEN, RICHARD (CHIEF OPERATING OFFICER)